Katherine Pratte, MSPH, PhD
Katherine A. Pratte, MSPH, PhD, is a researcher at National Jewish Health. Dr. Pratte is in the Division of Biostatistics and Bioinformatics.
Special Interests
Proteomic and multi-omics research
Research Interests
Observational and clinical trials
Pulmonary disorders
Cardiovascular disease
Diabetes
Education
Education
- 2015 - 2017
- University of Colorado Denver, Aurora, Co, PhD Clinical Science
- 2004 - 2006
- University of Colorado Health Science Center, Denver, Co, MSPH Epidemiology/Biostatistics
- 1972 - 1975
- Northwestern State University, Natchitoches, La, BS Microbiology & Zoology
Publications
Serban KA, Pratte KA, Strange C, et al. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease. EBioMedicine. 2022;84:104262.
Godbole S, Labaki WW, Pratte KA, et al. A Metabolomic Severity Score for Airflow Obstruction and Emphysema. Metabolites. 2022;12(5).
Axelsson GT, Gudmundsson G, Pratte KA, et al. The Proteomic Profile of Interstitial Lung Abnormalities. Am J Respir Crit Care Med. 2022;206(3):337-346.
Serban KA, Pratte KA, Bowler RP. Protein Biomarkers for COPD Outcomes. Chest. 2021;159(6):2244-2253.
Pratte KA, Curtis JL, Kechris K, et al. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD. Respir Res. 2021;22(1):127.